Indications and guidelines for the use of hematopoietic growth factors
- 12 November 1993
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 33 (11) , 944-959
- https://doi.org/10.1046/j.1537-2995.1993.331194082388.x
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infantsThe Journal of Pediatrics, 1992
- Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot studyThe Journal of Pediatrics, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot studyThe Journal of Pediatrics, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital AgranulocytosisNew England Journal of Medicine, 1989
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987